NewEdge Wealth’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Buy |
64,218
+6,199
| +11% | +$233K | 0.04% | 342 |
|
|
2025
Q1 | $2.25M | Buy |
58,019
+7,009
| +14% | +$272K | 0.04% | 333 |
|
|
2024
Q4 | $1.73M | Buy |
51,010
+9,613
| +23% | +$325K | 0.03% | 383 |
|
|
2024
Q3 | $1.69M | Buy |
41,397
+2,111
| +5% | +$86.3K | 0.03% | 376 |
|
|
2024
Q2 | $1.51M | Buy |
39,286
+229
| +0.6% | +$8.82K | 0.03% | 356 |
|
|
2024
Q1 | $1.69M | Sell |
39,057
-279
| -0.7% | -$12.1K | 0.04% | 353 |
|
|
2023
Q4 | $1.46M | Sell |
39,336
-1,044
| -3% | -$38.7K | 0.04% | 342 |
|
|
2023
Q3 | $1.46M | Sell |
40,380
-20
| -0% | -$725 | 0.05% | 306 |
|
|
2023
Q2 | $1.44M | Buy |
40,400
+5,117
| +15% | +$182K | 0.05% | 304 |
|
|
2023
Q1 | $1.26M | Buy |
35,283
+5,751
| +19% | +$205K | 0.05% | 286 |
|
|
2022
Q4 | $1.04M | Sell |
29,532
-963
| -3% | -$33.8K | 0.04% | 285 |
|
|
2022
Q3 | $897K | Buy |
30,495
+2,335
| +8% | +$68.7K | 0.04% | 281 |
|
|
2022
Q2 | $1.53M | Buy |
28,160
+18,573
| +194% | +$1.01M | 0.07% | 225 |
|
|
2022
Q1 | $522K | Buy |
9,587
+5,028
| +110% | +$274K | 0.02% | 297 |
|
|
2021
Q4 | $251K | Buy |
+4,559
| New | +$251K | 0.01% | 361 |
|